Dr. Lei Ma 马磊
Chief Physician
Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of lymphoma, nasopharyngeal cancer, lung cancer, breast cancer, and colon cancer. Focuses on full-course management, precision therapy for advanced tumors, and emergency care for critically ill patients.
Dr. Ma is Deputy Director of Internal Medicine and a Chief Physician with a PhD in Oncology. Trained at Tongji Medical University (1997), Guangzhou Medical College (2005), and Southern Medical University (2012). With over ten years of clinical experience, Dr. Ma leads multiple provincial research projects on tumor drug resistance and has published over 30 papers.
Name order: in Chinese the family name comes first (Ma Lei). Papers usually list the name as Lei Ma or Ma L.
Selected publications
26 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Pathol Res Pract, 2021 (senior author): High miR-3650 expression in nasopharyngeal carcinoma and its clinical prognostic values. PubMed 34091390
- Oncotarget, 2017 (first author): Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer. PubMed 27911852
- Tumour Biol, 2016 (senior author): Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. PubMed 26676637
- Biochem Biophys Res Commun, 2014 (senior author): The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. PubMed 24845562
- Int J Clin Exp Pathol, 2014 (senior author): Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer. PubMed 25031750
- FEBS Lett, 2014 (first author): Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. PubMed 24613926
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion